ProAxsis is proud to be collaborating with Dr. Gunnar Schroeder and Prof. Cliff Taggart from the School of Medicine, Dentistry and Biomedical Science at Queen’s University Belfast, as part of the Horizon 2020-funded Marie Skłodowska-Curie doctoral training (SPaRK) programme. The SPaRK Programme is driven by the need to develop future leaders whose skills combine disciplinary excellence with a capacity for interdisciplinary, intersectoral and international working that creates genuinely disruptive thinkers. These are the thinkers who will have the edge in a highly competitive, global job market.
The team at Queen’s are offering an exciting new opportunity to study for an interdisciplinary PhD in the field of protease signalling, which will include a placement at the ProAxsis laboratory in Belfast, under the supervision of Prof. Brian Walker, a globally renowned expert in the field of protease detection.
Further details about the position can be found at the link below. Applications close at 1600h on the 11th April 2018. If you believe you have the required skill set and passion to take on this position then please follow the application guidelines for the SpaRK programme available online.
Related News
Following its previous success in the BioMedical Catalyst competition, ProAxsis Limited (www.proaxsis.com) has now gained further support for …
ProAxsis Ltd today announces that the company has signed a partnership agreement to develop activity-based immunoassays for …
ProAxsis Limited, the Belfast-based diagnostics company, is pleased to welcome back Elisha Cain, who re-joins the company …
